Amid a staggering 269% surge in U.S. sales, oral nicotine pouches like Zyn, Velo, and on! have taken the consumer market by storm. This rapid rise, heavily fueled by social media influencers touting the products as cognitive enhancers, has prompted medical experts to urge extreme caution regarding their long-term health impacts.
The products are frequently in the news as manufacturers scale up production. For instance, a massive \$600 million manufacturing facility is already producing Zyn in Aurora, Colorado, to keep pace with skyrocketing demand.
What Are Oral Nicotine Pouches?
Nicotine pouches are small, permeable packets containing tobacco-derived or synthetic nicotine, water, flavorings, and plant-based fibers. Users place the pouch between their lip and gum, allowing the oral mucosa to absorb the nicotine directly into the bloodstream. Unlike traditional smokeless tobacco (snus), these pouches do not contain actual tobacco leaf material.
Because cigarette smoking kills nearly half a million people in the U.S. each year, and e-cigarette vaping carries its own distinct health impacts, smokeless and vaporless alternatives are often perceived as safer. The FDA has even authorized the sale of certain pouch products due to their potential to reduce cigarette use. However, they are not officially on the agency’s list of approved smoking-cessation products.
“The perceived benefits of nicotine come with real costs,” warns Dr. Gina Kruse, an internal medicine specialist at UCHealth University of Colorado Hospital. Dr. Kruse, who also directs the Colorado Nicotine, E-Cigarettes, and Tobacco Research Alliance (CoNECTR) and serves as a professor at the University of Colorado Anschutz School of Medicine, emphasizes that research on these products is still in its infancy.
The Science of Addiction: How Pouches Hook the Brain
Nicotine is incredibly effective at hijacking the brain’s chemistry. It triggers and enhances cognitive and sensory pathways by mimicking acetylcholine, a natural neurotransmitter. This action releases a flood of dopamine, creating a temporary sense of pleasure and alertness.
While online influencers claim pouches act as “brain boosters” that improve focus, Dr. Kruse points out that these benefits are short-lived. Furthermore, many studies claiming cognitive benefits received funding from the tobacco industry and failed to account for the cognitive deficits that occur during withdrawal.
Because nicotine ranks among the world’s most addictive substances, quitting these pouches isn’t easy. Unlike slow-release nicotine patches used for quitting smoking, oral pouches deliver a rapid spike of nicotine within minutes. When this surge quickly fades, it leaves users irritable, anxious, and craving another dose.
The Rise in Youth Usage
The rapid adoption of nicotine pouches among middle and high school students has raised alarms among public health officials. Because the brain continues to develop until age 25, early nicotine exposure carries known dangers, including permanent changes to attention span, impulse control, and mood regulation.
The table below highlights the growing footprint of nicotine pouches compared to e-cigarettes among U.S. youth as of 2025:
| Product Type | Middle School Usage (Past 30 Days) | High School Usage (Past 30 Days) |
|---|---|---|
| Nicotine Pouches | 0.9% | 2.3% |
| Nicotine Vapes (E-Cigarettes) | 2.6% | 7.1% |
While vaping remains more prevalent, the rapid jump 269% in pouch sales indicates a shifting trend that could hook a new generation on nicotine.
Are Nicotine Pouches Safe and Carcinogen-Free?
Because they do not involve combustion, nicotine pouches do not release the toxic smoke or tar associated with lung cancer. Pure nicotine itself is not considered a direct carcinogen.
However, the manufacturing process can introduce impurities. A study funded by Swedish Match (the maker of Zyn) tested their products and reported virtually no harmful constituents. Conversely, an independent German study analyzing 44 different nicotine pouches detected cancer-causing tobacco-specific nitrosamines in 26 of them.
“Given how long these products have been on the market, and that the health data we have is largely from industry-funded studies… we really don’t have that much concrete data to say what the harms and risks of these products are yet,” Dr. Kruse concludes. Until independent, long-term studies are completed, consumers should treat these highly addictive pouches with skepticism.